Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $255 to $271.
Morgan Stanley Maintains Equal-Weight on CME Group, Raises Price Target to $271
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $255 to $271.